Cingulate (CINGW) to Release Quarterly Earnings on Friday

Cingulate (NASDAQ:CINGW) is expected to be releasing its results before the market opens on Friday, March 6th. Analysts expect Cingulate to post earnings of ($0.6320) per share for the quarter.

Cingulate Stock Down 9.9%

CINGW stock opened at $0.04 on Friday. The business has a 50 day moving average of $0.07 and a 200-day moving average of $0.06. Cingulate has a 12-month low of $0.02 and a 12-month high of $0.18.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.